BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20737575)

  • 1. Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.
    Zhang J; Guo H; Zhang H; Wang H; Qian G; Fan X; Hoffman AR; Hu JF; Ge S
    Cancer; 2011 Jan; 117(1):86-95. PubMed ID: 20737575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1.
    Wu P; Liang J; Yu F; Zhou Z; Tang J; Li K
    Oncotarget; 2016 Jul; 7(27):42241-42251. PubMed ID: 27304058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.
    Ban J; Jug G; Mestdagh P; Schwentner R; Kauer M; Aryee DN; Schaefer KL; Nakatani F; Scotlandi K; Reiter M; Strunk D; Speleman F; Vandesompele J; Kovar H
    Oncogene; 2011 May; 30(18):2173-80. PubMed ID: 21217773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.
    Moore C; Parrish JK; Jedlicka P
    PLoS One; 2017; 12(5):e0178028. PubMed ID: 28542597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway.
    Li L; Song W; Yan X; Li A; Zhang X; Li W; Wen X; Zhou L; Yu D; Hu JF; Cui J
    Oncotarget; 2017 Jun; 8(26):41975-41987. PubMed ID: 28410216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.
    Wang J; Wang C; Hu A; Yu K; Kuang Y; Gajendran B; Zacksenhaus E; Sample KM; Xiao X; Liu W; Ben-David Y
    BMC Cancer; 2024 Mar; 24(1):326. PubMed ID: 38461240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.
    Schwentner R; Herrero-Martin D; Kauer MO; Mutz CN; Katschnig AM; Sienski G; Alonso J; Aryee DN; Kovar H
    Oncotarget; 2017 Feb; 8(7):10980-10993. PubMed ID: 28030800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors.
    Li Y; Li X; Fan G; Fukushi J; Matsumoto Y; Iwamoto Y; Zhu Y
    Cancer Lett; 2012 Jul; 320(1):14-22. PubMed ID: 22266186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.
    Scheiber MN; Watson PM; Rumboldt T; Stanley C; Wilson RC; Findlay VJ; Anderson PE; Watson DK
    Neoplasia; 2014 Oct; 16(10):801-13. PubMed ID: 25379017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.
    Jin Y; Cheng H; Cao J; Shen W
    J Cell Biochem; 2019 Nov; 120(11):18629-18639. PubMed ID: 31338872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.
    Miao B; Bauer AS; Hufnagel K; Wu Y; Trajkovic-Arsic M; Pirona AC; Giese N; Taipale J; Siveke JT; Hoheisel JD; Lueong S
    Int J Cancer; 2020 Jul; 147(1):189-201. PubMed ID: 31846072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1.
    Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q
    Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.
    Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK
    Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.
    Sohn EJ; Li H; Reidy K; Beers LF; Christensen BL; Lee SB
    Cancer Res; 2010 Feb; 70(3):1154-63. PubMed ID: 20103643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells.
    Nozawa S; Ohno T; Banno Y; Dohjima T; Wakahara K; Fan DG; Shimizu K
    J Biol Chem; 2005 Jul; 280(30):27544-51. PubMed ID: 15919668
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Li L; Li W; Chen N; Zhao H; Xu G; Zhao Y; Pan X; Zhang X; Zhou L; Yu D; Li A; Hu JF; Cui J
    Clin Cancer Res; 2019 Feb; 25(4):1302-1317. PubMed ID: 30429198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
    Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
    Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EWS-Fli1 up-regulates expression of the Aurora A and Aurora B kinases.
    Wakahara K; Ohno T; Kimura M; Masuda T; Nozawa S; Dohjima T; Yamamoto T; Nagano A; Kawai G; Matsuhashi A; Saitoh M; Takigami I; Okano Y; Shimizu K
    Mol Cancer Res; 2008 Dec; 6(12):1937-45. PubMed ID: 19074838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.